{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T09:04:50Z","timestamp":1649063090111},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s00393-014-1479-8","type":"journal-article","created":{"date-parts":[[2015,5,11]],"date-time":"2015-05-11T09:09:05Z","timestamp":1431335345000},"page":"310-321","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prognose und Therapie von entz\u00fcndlich-rheumatischen Erkrankungen"],"prefix":"10.1007","volume":"74","author":[{"given":"M.","family":"Z\u00e4nker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.D.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.D.","family":"Rupprecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,5,13]]},"reference":[{"key":"1479_CR1","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1681\/ASN.2008101028","volume":"20","author":"Appel","year":"2009","unstructured":"Appel GB, Contreras G, Dooley MA et al (2009) Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis. J Am Soc Nephrol 20:1103\u20131112","journal-title":"J Am Soc Nephrol"},{"key":"1479_CR2","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1136\/annrheumdis-2011-200726","volume":"71","author":"Avina-Zubieta","year":"2012","unstructured":"Avina-Zubieta JA, Thomas J, Sadatsafavi M et al (2012) Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis 71:1524\u20131529","journal-title":"Ann Rheum Dis"},{"key":"1479_CR3","doi-asserted-by":"crossref","first-page":"110778","DOI":"10.1371\/journal.pone.0110778","volume":"9","author":"Bagnasco","year":"2014","unstructured":"Bagnasco SM, Gottipati S, Kraus E et al (2014) Sarcoidosis in native and transplanted kidneys: incidence, pathologic findings, and clinical course. PLoS One 9:110778","journal-title":"PLoS One"},{"key":"1479_CR4","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1681\/ASN.2010050477","volume":"21","author":"Berden","year":"2010","unstructured":"Berden AE, Ferrario F, Hagen EC et al (2010) Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol 21:1628\u20131636","journal-title":"J Am Soc Nephrol"},{"key":"1479_CR5","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000356084","volume":"36","author":"Betjes","year":"2013","unstructured":"Betjes MGH, Meijers RWJ, Litjens NHR (2013) Loss of renal function causes premature aging of the immune system. Blood Purif 36:173\u2013178","journal-title":"Blood Purif"},{"key":"1479_CR6","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0272-6386(03)00025-8","volume":"41","author":"Booth","year":"2003","unstructured":"Booth AD, Almond MK, Burns A et al (2003) Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study. Am J Kidney Dis 41:776\u2013784","journal-title":"Am J Kidney Dis"},{"key":"1479_CR7","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1093\/ndt\/16.12.2328","volume":"16","author":"Bossini","year":"2001","unstructured":"Bossini N, Savoldi S, Franceschini F et al (2001) Clinical and morphological features of kidney involvement in primary Sj\u00f6gren\u2019s syndrome. Nephrol Dial Transplant 16:2328\u20132336","journal-title":"Nephrol Dial Transplant"},{"key":"1479_CR8","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s00296-014-2993-3","volume":"34","author":"Both","year":"2014","unstructured":"Both T, Zietse R, Hoorn EJ et al (2014) Everything you need to know about distal renal tubular acidosis in autoimmune disease. Rheumatol Int 34:1037\u20131045","journal-title":"Rheumatol Int"},{"key":"1479_CR9","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1001\/archinte.165.22.2659","volume":"165","author":"Brugts","year":"2005","unstructured":"Brugts JJ, Knetsch AM, Mattace-Raso FS et al (2005) Renal function and risk of myocardial infarction in an elderly population: the rotterdam study. Arch Intern Med 165:2659\u20132665","journal-title":"Arch Intern Med"},{"key":"1479_CR10","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1093\/rheumatology\/ker112","volume":"50","author":"Corral-Gudino","year":"2011","unstructured":"Corral-Gudino L, Borao-Cengotita-Bengoa M, Pino-Montes J del (2011) Overall survival, renal survival and relapse in patients with microscopic polyangiitis: a systematic review of current evidence. Rheumatology 50:1414\u20131423","journal-title":"Rheumatology"},{"key":"1479_CR11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/0961203312465781","volume":"22","author":"Dooley","year":"2013","unstructured":"Dooley MA, Houssiau F, Aranow C et al (2013) Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE. Lupus 22:63\u201372","journal-title":"Lupus"},{"key":"1479_CR12","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1053\/ajkd.1998.v32.pm9820470","volume":"32","author":"Foley","year":"1998","unstructured":"Foley RN, Parfrey PS, Sarnak MJ (1998) Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32(Suppl 3):112\u2013119","journal-title":"Am J Kidney Dis"},{"key":"1479_CR13","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1093\/ndt\/14.12.2807","volume":"14","author":"Girndt","year":"1999","unstructured":"Girndt M, Sester U, Sester M et al (1999) Impaired cellular immune function in patients with end-stage renal failure. Nephrol Dial Transplant 14:2807\u20132810","journal-title":"Nephrol Dial Transplant"},{"key":"1479_CR14","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","volume":"351","author":"Go","year":"2004","unstructured":"Go AS, Chertow GM, Fan D et al (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351:1296\u20131305","journal-title":"N Engl J Med"},{"key":"1479_CR15","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1002\/art.38100","volume":"65","author":"Goules","year":"2013","unstructured":"Goules AV, Tatouli IP, Moutsopoulos HM et al (2013) Clinically significant renal involvement in primary sj\u00f6gren\u2019s syndrome: clinical presentation and outcome. Arthritis Rheum 65:2945\u20132953","journal-title":"Arthritis Rheum"},{"key":"1479_CR16","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3949\/ccjm.79a.11066","volume":"79","author":"De","year":"2012","unstructured":"De Groot K (2012) Renal disease in small-vessel vasculitis. Cleve Clin J Med 79(Suppl 3):22\u201326","journal-title":"Cleve Clin J Med"},{"key":"1479_CR17","doi-asserted-by":"crossref","first-page":"670","DOI":"10.7326\/0003-4819-150-10-200905190-00004","volume":"150","author":"De","year":"2009","unstructured":"De Groot K, Harper L, Jayne DRW et al (2009) Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial. Ann Intern Med 150:670\u2013680","journal-title":"Ann Intern Med"},{"key":"1479_CR18","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1056\/NEJMoa1404231","volume":"371","author":"Guillevin","year":"2014","unstructured":"Guillevin L, Pagnoux C, Karras A et al (2014) Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis. N Engl J Med 371:1771\u20131780","journal-title":"N Engl J Med"},{"key":"1479_CR19","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/anr.1780320911","volume":"32","author":"Helfrich","year":"1989","unstructured":"Helfrich DJ, Banner B, Steen VD et al (1989) Normotensive renal failure in systemic sclerosis. Arthritis Rheum 32:1128\u20131134","journal-title":"Arthritis Rheum"},{"key":"1479_CR20","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1002\/art.10461","volume":"46","author":"Houssiau","year":"2002","unstructured":"Houssiau FA, Vasconcelos C, D\u2019Cruz D et al (2002) Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide. Arthritis Rheum 46:2121\u20132131","journal-title":"Arthritis Rheum"},{"key":"1479_CR21","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/ndt\/gfm851","volume":"23","author":"Janus","year":"2008","unstructured":"Janus N, Vacher L-V, Karie S et al (2008) Vaccination and chronic kidney disease. Nephrol Dial Transplant 23:800\u2013807","journal-title":"Nephrol Dial Transplant"},{"key":"1479_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA et al (2013) 2012 revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum 65:1\u201311","journal-title":"Arthritis Rheum"},{"key":"1479_CR23","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa0909169","volume":"363","author":"Jones","year":"2010","unstructured":"Jones RB, Tervaert JWC, Hauser T et al (2010) Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med 363:211\u2013220","journal-title":"N Engl J Med"},{"key":"1479_CR24","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.2215\/CJN.01020113","volume":"8","author":"Joode","year":"2013","unstructured":"Joode AAE de, Sanders JSF, Stegeman CA (2013) Renal survival in proteinase 3 and myeloperoxidase ANCA-associated systemic vasculitis. Clin J Am Soc Nephrol 8:1709\u20131717","journal-title":"Clin J Am Soc Nephrol"},{"key":"1479_CR25","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1007\/s10067-007-0625-y","volume":"26","author":"Karstila","year":"2007","unstructured":"Karstila K, Korpela M, Sihvonen S et al (2007) Prognosis of clinical renal disease and incidence of new renal findings in patients with rheumatoid arthritis: follow-up of a population-based study. Clin Rheumatol 26:2089\u20132095","journal-title":"Clin Rheumatol"},{"key":"1479_CR26","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1001\/jama.2014.7085","volume":"312","author":"Kohli","year":"2014","unstructured":"Kohli A, Shaffer A, Sherman A et al (2014) Treatment of hepatitis C: a systematic review. JAMA 312:631\u2013640","journal-title":"JAMA"},{"key":"1479_CR27","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S0272-6386(00)70262-9","volume":"35","author":"Korbet","year":"2000","unstructured":"Korbet SM, Lewis EJ, Schwartz MM et al (2000) Factors predictive of outcome in severe lupus nephritis. Lupus Nephritis Collaborative Study Group. Am J Kidney Dis 35:904\u2013914","journal-title":"Am J Kidney Dis"},{"key":"1479_CR28","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/rheumatology\/36.11.1189","volume":"36","author":"Korpela","year":"1997","unstructured":"Korpela M, Mustonen J, Teppo AM et al (1997) Mesangial glomerulonephritis as an extra-articular manifestation of rheumatoid arthritis. Br J Rheumatol 36:1189\u20131195","journal-title":"Br J Rheumatol"},{"key":"1479_CR29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1053\/j.ajkd.2010.08.019","volume":"56","author":"Korsten","year":"2010","unstructured":"Korsten P, Sweiss NJ, Nagorsnik U et al (2010) Drug-induced granulomatous interstitial nephritis in a patient with ankylosing spondylitis during therapy with adalimumab. Am J Kidney Dis 56:17\u201321","journal-title":"Am J Kidney Dis"},{"key":"1479_CR30","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1136\/ard.45.8.663","volume":"45","author":"Laakso","year":"1986","unstructured":"Laakso M, Mutru O, Isomaki H et al (1986) Mortality from amyloidosis and renal diseases in patients with rheumatoid arthritis. Ann Rheum Dis 45:663\u2013667","journal-title":"Ann Rheum Dis"},{"key":"1479_CR31","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1007\/s00296-012-2624-9","volume":"33","author":"Lee","year":"2013","unstructured":"Lee S-H, Lee EJ, Chung SW et al (2013) Renal involvement in ankylosing spondylitis: prevalence, pathology, response to TNF-a blocker. Rheumatol Int 33:1689\u20131692","journal-title":"Rheumatol Int"},{"key":"1479_CR32","doi-asserted-by":"crossref","unstructured":"Mah\u00e9vas M, Lescure FX, Boffa JJ et al (2009) Renal sarcoidosis: clinical, laboratory, and histologic presentation and outcome in 47 patients. Medicine (Baltimore) 88:98","DOI":"10.1097\/MD.0b013e31819de50f"},{"key":"1479_CR33","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1136\/ard.61.12.1065","volume":"61","author":"Manger","year":"2002","unstructured":"Manger K, Manger B, Repp R et al (2002) Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus. Ann Rheum Dis 61:1065\u20131070","journal-title":"Ann Rheum Dis"},{"key":"1479_CR34","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1136\/ard.2007.071936","volume":"67","author":"Mukhtyar","year":"2008","unstructured":"Mukhtyar C, Flossmann O, Hellmich B et al (2008) Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism Systemic Vasculitis Task Force. Ann Rheum Dis 67:1004\u20131010","journal-title":"Ann Rheum Dis"},{"key":"1479_CR35","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/ard.2008.088096","volume":"68","author":"Mukhtyar","year":"2009","unstructured":"Mukhtyar C, Guillevin L, Cid MC et al (2009) EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis 68:310\u2013317","journal-title":"Ann Rheum Dis"},{"key":"1479_CR36","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/art.1780400417","volume":"40","author":"Mustila","year":"1997","unstructured":"Mustila A, Korpela M, Mustonen J et al (1997) Perinuclear antineutrophil cytoplasmic antibody in rheumatoid arthritis: a marker of severe disease with associated nephropathy. Arthritis Rheum 40:710\u2013717","journal-title":"Arthritis Rheum"},{"key":"1479_CR37","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/rheumatology\/38.6.499","volume":"38","author":"Myllykangas-Luosuj\u00e4rvi","year":"1999","unstructured":"Myllykangas-Luosuj\u00e4rvi R, Aho K, Kautiainen H et al (1999) Amyloidosis in a nationwide series of 1666 subjects with rheumatoid arthritis who died during 1989 in Finland. Rheumatology 38:499\u2013503","journal-title":"Rheumatology"},{"key":"1479_CR38","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.berh.2004.03.002","volume":"18","author":"O","year":"2004","unstructured":"O\u2019Callaghan CA (2004) Renal manifestations of systemic autoimmune disease: diagnosis and therapy. Best Pract Res Clin Rheumatol 18:411\u2013427","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"1479_CR39","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/qjmed\/hcm052","volume":"100","author":"Penn","year":"2007","unstructured":"Penn H, Howie AJ, Kingdon EJ et al (2007) Scleroderma renal crisis: patient characteristics and long-term outcomes. QJM 100:485\u2013494","journal-title":"QJM"},{"key":"1479_CR40","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1111\/j.1600-6143.2005.01035.x","volume":"5","author":"Pham","year":"2005","unstructured":"Pham P-TT, Pham P-CT, Danovitch GM et al (2005) Predictors and risk factors for recurrent scleroderma renal crisis in the kidney allograft: case report and review of the literature. Am J Transplant 5:2565\u20132569","journal-title":"Am J Transplant"},{"key":"1479_CR41","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0140-6736(11)60242-0","volume":"379","author":"Ramos-Casals","year":"2012","unstructured":"Ramos-Casals M, Stone JH, Cid MC et al (2012) The cryoglobulinaemias. Lancet 379:348\u2013360","journal-title":"Lancet"},{"key":"1479_CR42","first-page":"278","volume":"35","author":"Ren","year":"2008","unstructured":"Ren H, Wang W-M, Chen X-N (2008) Renal involvement and followup of 130 patients with primary Sj\u00f6gren\u2019s syndrome. J Rheumatol 35:278\u2013284","journal-title":"J Rheumatol"},{"key":"1479_CR43","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/qjmed\/hcu043","volume":"107","author":"Romeu","year":"2014","unstructured":"Romeu M, Couchoud C, Delarozi\u00e8re JC et al (2014) Survival of patients with ANCA-associated vasculitis on chronic dialysis: data from the French REIN registry from 2002 to 2011. QJM 107:545\u2013555","journal-title":"QJM"},{"key":"1479_CR44","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1001\/archinte.166.19.2101","volume":"166","author":"Saadoun","year":"2006","unstructured":"Saadoun D, Sellam J, Ghillani-Dalbin P et al (2006) Increased risks of lymphoma and death among patients with non-hepatitis C virus-related mixed cryoglobulinemia. Arch Intern Med 166:2101\u20132108","journal-title":"Arch Intern Med"},{"key":"1479_CR45","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1182\/blood-2009-10-248518","volume":"116","author":"Saadoun","year":"2010","unstructured":"Saadoun D, Rigon MR, Sene D et al (2010) Rituximab plus Peg-interferon-\u03b1\/ribavirin compared with Peg-interferon-\u03b1\/ribavirin in hepatitis C\u2013related mixed cryoglobulinemia. Blood 116:326\u2013334","journal-title":"Blood"},{"key":"1479_CR46","first-page":"179","volume":"54","author":"Schwarz","year":"2000","unstructured":"Schwarz A, Krause PH, Kunzendorf U et al (2000) The outcome of acute interstitial nephritis: risk factors for the transition from acute to chronic interstitial nephritis. Clin Nephrol 54:179\u2013190","journal-title":"Clin Nephrol"},{"key":"1479_CR47","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1002\/1529-0131(199809)41:9<1613::AID-ART11>3.0.CO;2-O","volume":"41","author":"Steen","year":"1998","unstructured":"Steen VD, Medsger TA (1998) Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis. Arthritis Rheum 41:1613\u20131619","journal-title":"Arthritis Rheum"},{"key":"1479_CR48","doi-asserted-by":"crossref","first-page":"600","DOI":"10.7326\/0003-4819-133-8-200010170-00010","volume":"133","author":"Steen","year":"2000","unstructured":"Steen VD, Medsger TA (2000) Long-term outcomes of scleroderma renal crisis. Ann Intern Med 133:600\u2013603","journal-title":"Ann Intern Med"},{"key":"1479_CR49","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","volume":"363","author":"Stone","year":"2010","unstructured":"Stone JH, Merkel PA, Spiera R et al (2010) Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 363:221\u2013232","journal-title":"N Engl J Med"},{"key":"1479_CR50","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1756-185X.2009.01410.x","volume":"12","author":"Strange","year":"2009","unstructured":"Strange G, Nash P (2009) The manifestations of vasculopathy in systemic sclerosis and its evidence-based therapy. Int J Rheum Dis 12:192\u2013206","journal-title":"Int J Rheum Dis"},{"key":"1479_CR51","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/BF01451293","volume":"17","author":"Strobel","year":"1998","unstructured":"Strobel ES, Fritschka E (1998) Renal diseases in ankylosing spondylitis: review of the literature illustrated by case reports. Clin Rheumatol 17:524\u2013530","journal-title":"Clin Rheumatol"},{"key":"1479_CR52","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/BOR.0b013e32835b15f7","volume":"25","author":"Terrier","year":"2013","unstructured":"Terrier B, Cacoub P (2013) Cryoglobulinemia vasculitis: an update. Curr Opin Rheumatol 25:10\u201318","journal-title":"Curr Opin Rheumatol"},{"key":"1479_CR53","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1002\/art.30319","volume":"63","author":"Terrier","year":"2011","unstructured":"Terrier B, Semoun O, Saadoun D et al (2011) Prognostic factors in patients with hepatitis C virus infection and systemic vasculitis. Arthritis Rheum 63:1748\u20131757","journal-title":"Arthritis Rheum"},{"key":"1479_CR54","doi-asserted-by":"crossref","unstructured":"Terrier B, Karras A, Kahn J-E (2013) The spectrum of type I cryoglobulinemia vasculitis: new insights based on 64 cases. Medicine (Baltimore) 92:61\u201368","DOI":"10.1097\/MD.0b013e318288925c"},{"key":"1479_CR55","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.aogh.2013.12.007","volume":"80","author":"Tomey","year":"2014","unstructured":"Tomey MI, Winston JA (2014) Cardiovascular pathophysiology in chronic kidney disease: opportunities to transition from disease to health. Ann Glob Health 80:69\u201376","journal-title":"Ann Glob Health"},{"key":"1479_CR56","doi-asserted-by":"crossref","first-page":"605","DOI":"10.2147\/VHRM.S2453","volume":"4","author":"Turesson","year":"2008","unstructured":"Turesson C, Jacobsson LT, Matteson EL (2008) Cardiovascular co-morbidity in rheumatic diseases. Vasc Health Risk Manag 4:605\u2013614","journal-title":"Vasc Health Risk Manag"},{"key":"1479_CR57","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/ki.2013.131","volume":"84","author":"Walsh","year":"2013","unstructured":"Walsh M, Casian A, Flossmann O et al (2013) Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear. Kidney Int 84:397\u2013402","journal-title":"Kidney Int"},{"key":"1479_CR58","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1053\/j.ajkd.2007.04.018","volume":"50","author":"Weidanz","year":"2007","unstructured":"Weidanz F, Day CJ, Hewins P et al (2007) Recurrences and infections during continuous immunosuppressive therapy after beginning dialysis in ANCA-associated vasculitis. Am J Kidney Dis 50:36\u201346","journal-title":"Am J Kidney Dis"},{"key":"1479_CR59","first-page":"976","volume":"34","author":"Yoshida","year":"1994","unstructured":"Yoshida A, Morozumi K, Takeda A et al (1994) Nephropathy in patients with mixed connective tissue disease. Ryumachi Rheum 34:976\u2013980","journal-title":"Ryumachi Rheum"},{"key":"1479_CR60","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/kisup.2012.25","volume":"2","author":"KDIGO","year":"2012","unstructured":"KDIGO guidelines (2012) KDIGO guidelines, Chapter 12: Lupus nephritis. Kidney Int 2(Suppl):221\u2013232","journal-title":"Kidney Int"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-014-1479-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-014-1479-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-014-1479-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,24]],"date-time":"2019-08-24T18:35:21Z","timestamp":1566671721000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-014-1479-8"}},"subtitle":["Einfluss der Nierenbeteiligung"],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["1479"],"URL":"https:\/\/doi.org\/10.1007\/s00393-014-1479-8","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5]]}}}